Prostatis Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,946
| Closed | -$305K | – | 147 |
|
|
2023
Q4 | $305K | Buy |
1,946
+138
| +8% | +$21.6K | 0.13% | 104 |
|
|
2023
Q3 | $300K | Sell |
1,808
-72,516
| -98% | -$12M | 0.15% | 86 |
|
|
2023
Q2 | $308K | Buy |
74,324
+68,564
| +1,190% | +$284K | 0.14% | 89 |
|
|
2023
Q1 | $902K | Sell |
5,760
-183
| -3% | -$28.7K | 0.48% | 51 |
|
|
2022
Q4 | $1.05M | Buy |
5,943
+4,250
| +251% | +$751K | 0.64% | 40 |
|
|
2022
Q3 | $277K | Sell |
1,693
-26
| -2% | -$4.25K | 0.32% | 45 |
|
|
2022
Q2 | $305K | Buy |
1,719
+278
| +19% | +$49.4K | 0.48% | 23 |
|
|
2022
Q1 | $255K | Sell |
1,441
-153
| -10% | -$27.1K | 0.2% | 69 |
|
|
2021
Q4 | $273K | Sell |
1,594
-4,874
| -75% | -$834K | 0.17% | 81 |
|
|
2021
Q3 | $1.04M | Buy |
6,468
+295
| +5% | +$47.6K | 0.62% | 39 |
|
|
2021
Q2 | $1.02M | Buy |
6,173
+952
| +18% | +$157K | 0.69% | 37 |
|
|
2021
Q1 | $858K | Buy |
5,221
+853
| +20% | +$140K | 0.67% | 31 |
|
|
2020
Q4 | $687K | Buy |
4,368
+917
| +27% | +$144K | 0.58% | 40 |
|
|
2020
Q3 | $514K | Buy |
3,451
+871
| +34% | +$130K | 0.49% | 44 |
|
|
2020
Q2 | $363K | Buy |
2,580
+935
| +57% | +$131K | 0.73% | 41 |
|
|
2020
Q1 | $216K | Sell |
1,645
-61
| -4% | -$8K | 0.31% | 49 |
|
|
2019
Q4 | $249K | Buy |
+1,706
| New | +$249K | 0.22% | 75 |
|